Acute lymphoblastic/lymphocytic leukemia is one of the most common type of cancers that mainly affects children. There are two types of acute lymphocytic leukemia; B-cell type and T-cell type, that can be treated by radiation therapy, chemotherapy, targeted therapy, and others. The global acute lymphocytic leukemia market is expected to witness considerable growth during the forecast period. Increasing prevalence of acute lymphoblastic leukemia is encouraging the players in the market to develop innovative treatments to cure such diseases; thereby, contributing to the growth of the market. According to the National Cancer Institute in 2017, the number of new cases of acute lymphoblastic leukemia in the US was around 1.7 per 100,000 population. With the increasing cases of acute lymphoblastic leukemia, the market players are focusing more on clinical trials, which is expected to fuel the market growth in the near future.

Request a free sample of our report on Global Acute Lymphoblastic Leukemia Market: https://www.omrglobal.com/request-sample/acute-lymphoblastic-leukemia-market

 

The acute lymphoblastic leukemia market is segmented on the basis of cell type, treatment, and end-user. The market on the basis of cell type is bifurcated into B-cell type and T-Cell type. B-cell type segment is expected to contribute significantly to the growth of the market as 75% of acute lymphoblastic leukemia cases in adults develop from precursors of the B-cell lineage in the US, according to the National Institute of Health in 2017. As per treatment, the market is segmented into chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplantation. Among these, chemotherapy is expected to hold significant share in the global acute lymphoblastic leukemia market.

A full report of Global Acute Lymphoblastic Leukemia Market Is available at  https://www.omrglobal.com/industry-reports/acute-lymphoblastic-leukemia-market 

Global Acute Lymphoblastic Leukemia Market Segmentation

By Cell Type

B-Cell

T-Cell

By Treatment

Chemotherapy

Radiation Therapy

Targeted Therapy

Immunotherapy

Stem Cell Transplantation

By End-User

Hospitals and Clinics

Research Institutes

Regional Analysis

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

India

Japan

Rest of Asia-Pacific

Rest of the World

Company Profiles

AbbVie, Inc.

Adaptive Biotechnologies Corp.

Amgen, Inc.

AstraZeneca PLC

Atara Biotherapeutics, Inc.

Athenex, Inc.

Baxter International, Inc.

Blubird Bio, Inc.

Bristol-Myers Squibb Co.

Cabaletta Bio, Inc.

For more customized data, request for report customization @  https://www.omrglobal.com/report-customization/acute-lymphoblastic-leukemia-market 

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact: 

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404